Stocktoria
Jin Medical International Ltd. ZJYL
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2023-03-28
Jin Medical International Ltd. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $20.7M | $23.5M | $19.8M | $19.2M |
| Gross profit | $6.0M | $9.5M | $6.8M | $6.2M |
| R&D expense | $1.6M | $1.5M | $1.5M | $1.9M |
| Operating income | $608,182 | $3.6M | $2.9M | $2.1M |
| Income tax | $214,572 | $763,879 | $343,707 | $36,111 |
| Net income | $1.2M | $3.7M | $2.9M | $2.7M |
| EPS (diluted) | $0.01 | $0.02 | $0.02 | $0.02 |
| Operating cash flow | $2.9M | -$1.2M | $3.1M | $1.6M |
| Free cash flow | -$3.7M | -$1.4M | $3.0M | $1.5M |
| Inventory | $4.9M | $5.2M | $5.1M | $6.7M |
| Total assets | $53.4M | $45.8M | $32.9M | $20.9M |
| Total liabilities | $23.8M | $17.2M | $8.9M | $5.7M |
| Shareholders' equity | $29.6M | $28.8M | $24.0M | $15.2M |
Source: SEC EDGAR filings · CIK 0001837821 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.